Articles

The list below contains peer-reviewed articles to which I contributed. On Google Scholar you can find a list of citations to my articles.

2021

54  Pietrasik A., Gąsecka A., Pieniak K., Karpiński G., Kochman J., Darocha S., Kurzyna M.
Iatrogenic embolism caused by fractured vascular port: successful endovascular treatment
 Kardiol. Pol. 2021; [ahead of print].
53  Pietrasik A., Gąsecka A., Leśniewski M., Zieliński D., Darocha S., Kurzyna M.
Hybrid treatment of massive pulmonary embolism by catheter-directed and surgical embolectomy
Postepy Kardiol. Interwencyjnej. 2021; [ahead of print].
52  Szarpak L., Michalski T.A., Smereka J., Gasecka A., Pruc M., Jaguszewski M.J.
Efficacy and safety of ticagrelor use in pre-hospital setting
 Am. J. Emerg. Med. 2021; [ahead of print].
51  Szarpak L., Ruetzler K., Figatowski T., Pruc M., Gasecka A., Jaguszewski M.J., Filipiak K.J.
Efficacy and safety of prasugrel and clopidogrel in ST-segment elevation myocardial infarction in prehospital setting
 Am. J. Emerg. Med. 2021; [ahead of print].
50  Szarpak L., Rafique Z., Gasecka A., Jaguszewski M.J., Filipiak K.J.
Tirofiban in emergency conditions: Systematic review
 Am. J. Emerg. Med. 2021; [ahead of print].
49  Pietrasik A., Gąsecka A., Chojecka D., Pytlos J., Rymuza B., Główczyńska R., Banaszkiewicz M., Darocha S., Kurzyna M.
Iatrogenic pulmonary embolism with cyanoacrylate: to remove or to leave?
 Kardiol. Pol. 2021; [ahead of print].
48  Dudek M., Szarpak L., Peacock F. W., Gasecka A., Michalski T., Wroblewski P., Kaminska H., Borkowska G., Skrzypek E., Smereka A., Meyer-Szary J., Marciniak S., Malecka M.
Diagnostic performance of point-of-use ultrasound of resuscitation outcomes: A systematic review and metaanalysis of 3265 patients
 Cardiol. J. 2021; [ahead of print].
47  Szarpak L., Borkowska M., Peacock F.W., Rafique Z., Gasecka A., Smereka J., Pytkowska K., Jachowicz M., Iskrzycki L., Gilis-Malinowska N., Jaguszewski M.J.
Characteristics and outcomes of in-hospital cardiac arrest in COVID-19. A systematic review and meta-analysis
 Cardiol. J. 2021; [ahead of print].
46  Czajka P., Fitas A., Jakubik D., Eyileten C., Gasecka A., Wicik Z., Siller-Matula J., Filipiak K.J., Postula M.
MicroRNA as potential biomarkers for platelet function: a review
 FrontiersPhysiol. 2021; [ahead of print].
45  Wieczorek W., Meyer-Szary J., Jaguszewski M.J., Filipiak K.J., Cyran M., Smereka J., Gasecka A., Ruetzler K., Szarpak L.
Efficacy of Targeted Temperature Management after Pediatric Cardiac Arrest: A Meta-Analysis of 2002 Patients
 J. Clin. Med. 2021; 10, 1389.
44  Gasecka A., Pruc M., Kukula K., Gilis-Malinowka N., Filipiak K.J., Jaguszewski M.J., Szarpak L.
Post-COVID-19 heart syndrome
 Cardiol. J. 2021; [ahead of print].
43  Kaminska H., Szarpak L., Kosior D., Wieczorek W., Szarpak A., Al‑Jeabory M., Gawel W., Gasecka A., Jaguszewski M.J., Jarosz‑Chobot P.
Impact of diabetes mellitus on in‑hospital mortality in adult patients with COVID‑19: a systematic review and meta‑analysis
 Acta Diabetologica. 2021; [ahead of print].
42  Jaguszewski M.J., Gąsecka A., Targoński R., Filipiak K.J., Szarpak L.
Efficacy and safety of levosimendan and dobutamine in heart failure: a systematic review and meta-analysis
 Cardiol. J. 2021; [ahead of print].
41  Konwerski M., Postuła M., Barczuk-Falęcka M., Czajkowska A., Mróz A., Witek K., Bakalarski W., Gąsecka A., Małek Ł.A., Mazurek T.
Epicardial adipose tissue and cardiovascular risk assessment in ultra-marathon runners
 Int. J. Environ. Res. Public Health. 2021; 18, 3136.
40  Borkowska M.J., Jaguszewski M.J., Koda M., Gasecka A., Szarpak A., Gilis-Malinowska N., Safiejko K., Szarpak L., Filipiak K.J., Smereka J.
Impact of Coronavirus Disease 2019 on out-of-hospital cardiac arrest survival rate: a systematic review with meta-analysis
 J. Clin. Med. 2021; 10, 1209.
39  Al-Jeabory M., Szarpak L., Kecskes A., Simpson M., Smereka A., Gasecka A., Wieczorek W., Pruc M., Koselak M., Gawel W., Chęciński I., Jaguszewski M.J., Filipiak K.J.
Efficacy and safety of tranexamic acid in trauma patients in emergency medicine: a systematic review and meta-analysis of 30,571 patients
 J. Clin. Med. 2021; 10, 1030.
38  Gasecka A., Banaszkiewicz M., Nieuwland R., van der Pol E., Hajji N., Mutwil H., Rogula S., Rutkowska W., Pluta K., Eyileten C., Postula M., Darocha S., Huczek Z., Opolski G., Filipiak K.J., Torbicki A., Kurzyna M.
Prostacyclin analogues inhibit platelet reactivity, extracellular vesicle release and thrombus formation in patients with pulmonary arterial hypertension
 J. Clin. Med. 2021; 10, 1024.
37  Jaguszewski M.J., Gasecka A., Filipiak K.J., Szarpak L.
Levosimendan or dobutamine in patients with low cardiac output syndrome: results from meta-analysis
Int. J. Card. 2021; [ahead of print].
36  Al-Jeabory M., Gasecka A., Wieczorek W., Meyer-Szary J., Jaguszewski M.J., Szarpak L.
Efficacy and safety of tranexamic acid in pediatric trauma patients: evidence from meta-analysis
 Am. J. Emerg. Med. 2021; [ahead of print].
35  Papakonstantinou P.E., Borovac J.A., Gasecka A., Bongiovanni D., Ehrlinder H., Giustozzi M., Parker W.A.E., Azevedo Guerreiro R.
Anticoagulation therapy in non-valvular atrial fibrillation in the COVID-19 era: Is it time to reconsider our therapeutic strategy?
 Eur. J. Prev. Cardiol. 2021; [ahead of print].
34  Gasecka A., Pluta K., Solarska K., Rydz B., Eyileten C., Postuła M., van der Pol E., Nieuwland R., Budnik M., Kochanowski J., Jaguszewski M., Szarpak L., Mazurek T., Kapłon-Cieślicka A., Opolski G., Filipiak K.J.
Plasma concentrations of extracellular vesicles are decreased in patients with post-infarct cardiac remodelling
 Biology 2021; 10: 97.
33  Szarpak Ł., Gasecka A., Gilis-Malinowska N, Filipiak K.J., Jaguszewski M.J.
Copeptin level differentiates takotsubo cardiomyopathy from acute myocardial infarction
 Biomarkers 2021; [ahead of print].
32  Gasecka A., Rogula S., Szarpak Ł., Filipiak K.J.
LDL-cholesterol and platelets: insights into their interactions in atherosclerosis
 Life 2021; 11: 39.

2020

31  Ruetzler K., Drozd A., Gasecka A., Bielski K., Wieczorek W., Al-Jeabory M., Hernik J., Szarpak Ł.
Pediatric intravascular access in simulated COVID-19 patients among paramedics wearing personal protective equipment(pdf, 3.1 MB)
 Resuscitation Plus 2020; [ahead of print].
30  Jarosz-Popek J., Wolska M., Gąsecka A., Czajka P., Jakubik D., Sharif L., Adem T., Wei-Ling L., Mirowska-Guzel D., Postula M., Eyileten C.
The importance of microRNAs and long non-coding RNAs in neurodegeneration and neuroregeneration processes in diabetes (pdf, 874 kB)
 J. Clin. Med. 2020; 10: 9.
29  Szarpak Ł., Filipiak K.J., Gasecka A., Pruc M., Drozd A., Jaguszewski M.J.
Correlation between takotsubo cardiomyopathy and SARS-CoV-2 infection (pdf, 475 kB)
 Medical Hypotheses. 2020; [ahead of print].
28  Al-Jeabory M., Safiejko K., Bialka S., Pruc M., Gasecka A., Szarpak L.
Impact of COVID-19 on bystander cardiopulmonary resuscitation in out-of-hospital cardiac arrest: Is it as bad as we think? (pdf, 242 kB)
 Cardiol. J. 2020; [ahead of print].
27  Trela M., Szarpak L., Filipiak K.J., Mayer-Szary J., Gilis-Malinowska N., Nadolny K., Gasecka A., Szarpak A., Smereka J., Jaguszewski M.J.
Why epinephrine should not always be used in pediatric cardiac arrest?
Kardiol. Pol. 2020; [ahead of print].
26  Szarpak L., Zaczynski A., Kosior D., Bialka S., Ładny J.R., Gilis-Malinowska N., Smereka J., Kanczuga-Koda L., Gasecka A., Filipiak K.J., Jaguszewski M.J.
Evidence of diagnostic value of ferritin in patients with COVID-19 (pdf, 367 kB)
 Cardiol. J. 2020; [ahead of print].
25  Zawadka M., Marchel M., Dudek P., Andruszkiewicz P., Jakimowicz T., Gąsecka A., Kutka M., Poelaert J.
Cardiac stress in high risk patients undergoing major endovascular surgery – focus on diastolic function
J. Cardiothorac. Vasc. Anesth. 2020; [ahead of print].
24  Ruetzler K., Szarpak L., Ładny J. R., Gąsecka A., Gilis-Malinowska N., Pruc M., Smereka J., Nowak B., Filipiak K. J., Jaguszewski M. J.
D-dimer levels predict COVID-19 severity and mortality
Kardiol. Pol. 2020; [ahead of print].
23  Pieniak K., Jędrzejczyk S., Domaszk O., Grodecki K., Rymuza B., Huczek Z., Kochman J., Filipiak K. J., Gąsecka A.
Predictors and biomarkers of subclinical leaflet thrombosis after transcatheter aortic valve implantation (pdf, 853 kB)
 J. Clin. Med. 2020; 9: 3742.
22  Rogula S., Mutwil H., Gasecka A., Kurzyna M., Filipiak K.J.
Antiplatelet effects of prostacyclin analogues – which one to choose in case of thrombosis or bleeding? (pdf, 732 kB)
 Cardiol. J. 2020; [ahead of print].
21  Gąsecka A., Borovac J. A., Azevedo Guerreiro R., Giustozzi M., Parker W., Caldeira D., Chiva-Blanch G.
Thrombotic complications in patients with COVID-19: pathophysiological mechanisms, diagnosis and treatment (pdf, 630 kB)
 Cardiovasc. Drugs Ther. 2020; [ahead of print].
20  Gasecka A., Filipiak K.J., Jaguszewski M.J.
Impaired microcirculation function in COVID-19 and implications for potential therapies (pdf, 449 kB)
 Cardiol. J. 2020; 5: 485–488.
19  Gasecka A., Siwik D., Gajewska M., Jaguszewski M.J., Mazurek T., Filipiak K.J., Postuła M., Eyileten C.
Early biomarkers of neurodegenerative and neurovascular disorders in diabetes (pdf, 805 kB)
 J. Clin. Med. 2020; 9: 2807.
18  Gozdowska R., Makowska A., Gasecka A., Chabior A., Marchel M.
Circulating microRNA in heart failure - practical guidebook to clinical application (pdf, 1.19 MB)
 Cardiol. Rev. 2020; [ahead of print].
17  Gasecka A., Rogula S., Eyileten C., Postuła M., Jaguszewski M. J., Kochman J., Mazurek T., Nieuwland R., Filipiak K.J.
Role of P2Y Receptors in Platelet Extracellular Vesicle Release (pdf, 1944 kB)
 Int. J. Mol. Sci. 2020; 21: 6065
16  Gasecka A., Kruk K., Przybyłkowski A., Mazurek T., Kochman J., Filipiak K.J.
Persistent myocardial ischaemia due to anaemia in patient with coeliac disease: case report (pdf, 576 kB)
 Heart International. 2020; 14(1): 1-4

15  Biesinger B.S., Gasecka A., Perkmann T., Wojta J., Lesiak M., Grygier M., Eyileten C.,Postuła M.,Filipiak K.J., Toma A.,Hengstenberg C.,Siller-Matula J.M.
Inflammatory state does not affect the antiplatelet efficacy of potent P2Y12 inhibitors in ACS (pdf, 469 kB)
 Platelets. 2020; [ahead of print]
14  Marchel M., Gąsecka A., Czub P., Kochanowski J., Opolski G.
A dancing balloon in the right atrium - A rare presentation of MSSA cardiac device related infective endocarditis (pdf, 629 kB)
 Clin. Microbiol. Infect. 2020; 26(8): 1044-1045.

13  Gasecka A., Nieuwland R., Budnik M., Dignat-George F., Eyileten C., Harrison P., Lacroix R., Leroyer A., Opolski G., Pluta K., van der Pol E., Postuła M., Siljander P., Siller-Matula J.M., Filipiak K.J.
Ticagrelor attenuates the increase of extracellular vesicles concentrations in plasma after acute myocardial infarction compared to clopidogrel (pdf, 1348 kB)
 J. Thromb. Haemost. 2020; 18(3): 609-623.
12  Gasecka A., Nieuwland R., Budnik M., Dignat-George F., Eyileten C., Harrison P., Huczek Z., Kapłon-Cieślicka A., Lacroix R., Opolski G., Pluta K., van der Pol E., Postuła M., Leroyer A., Siljander P., Sturk A., Filipiak K.J.
Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction (pdf, 1824 kB)
 Platelets. 2020; 76(1): 26-32

2019

11  Jaworska K., Hering D., Mosieniak G., Bielak-Zmijewska A., Pilz M., Konwerski M., Gasecka A., Kapłon-Cieślicka A., Filipiak KJ., Sikora E., Hołyst R., Ufnal M.
TMA, A Forgotten Uremic Toxin, but Not TMAO, Is Involved in Cardiovascular Pathology (pdf, 1952 kB)
 Toxins (Basel). 2019; 11(9): 490.
10  Gasecka A., Konwerski M., Pordzik J., Soplińska A., Filipiak K.J., Siller-Matula J.M., Postuła M.
Switching between P2Y12 antagonists - From bench to bedside (pdf, 1415 kB)
 Vascul. Pharmacol. 2019; 115: 1-12
09  Gasecka A., Nieuwland R., van der Pol E., Hajji N., Ćwiek A., Pluta K., Konwerski M., Filipiak K.J.
P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets (pdf, 785 kB)
 Cardiol. J. 2019; 26 (6): 782-789.

2018

08  Tomaniak M., Sygitowicz G., Filipiak K.J., Błaszczyk O., Kołtowski Ł., Gąsecka A., Kochanowski J., Sitkiewicz D.
Dysregulations of miRNAs and galectin-3 may underlie left ventricular dilatation in patients with systolic heart failure (pdf, 190 kB)
 Kardiol. Pol. 2018; 76(6): 1012–1014
07  Varga Z., van der Pol E., Pálmai M., Garcia-Diez R., Gollwitzer C., Krumrey M., Fraikin J.L., Gasecka A., Hajji N., van Leeuwen T.G., Nieuwland R.
Hollow organosilica beads as reference particles for optical detection of extracellular vesicles (pdf, 768 kB)
 J. Thromb. Haemost. 2018; 16: 1646–1655.
06  Kubisa M.J., Jezewski M.P., Gasecka A., Siller-Matula J.M., Postuła M.
Ticagrelor - towards more efficient platelet inhibition and beyond (pdf, 1009 kB)
 Ther. Clin. Risk Manag. 2018; 14: 129-140.
05  Gasecka A., van der Pol E., Nieuwland R., Stępień E.
Extracellular vesicles in post-infarct ventricular remodelling (pdf, 625 kB)
 Kardiol. Pol. 2018; 76(1): 69-76

2017

04  Tomaniak M., Kołtowski Ł., Kochman J., Huczek Z., Rdzanek A., Pietrasik A., Gasecka A., Gajda S., Opolski G., Filipiak K.J.
Can prasugrel decrease the extent of periprocedural myocardial injury during elective percutaneous coronary intervention? (pdf, 224 kB)
 Pol. Arch. Intern. Med. 2017; 127(11): 730-740
03  Coumans F.A.W., Brisson A., Buzas E.I., Dignat-George F., Drees E.E.E., El-Andaloussi S., Emanueli C., Gasecka A., Hendrix A., Hill A.F., Lacroix R., Lee Y., van Leeuwen T.G., Mackman N., Mäger I., Nolan J., van der Pol E., Pegtel D.M., Sahoo S., Siljander P.R.M., Sturk A., de Wever O., Nieuwland R.
Methodological guidelines to study extracellular vesicles (pdf, 957 kB)
 Circ. Res. 2017; 120(10): 1632-1648
02  Gasecka A., Böing A.N., Filipiak K.J., Nieuwland R.
Platelet extracellular vesicles as biomarkers for arterial thrombosis (pdf, 837 kB)
 Platelets. 2017; 28(3): 228-234
01  Tomaniak M., Gasecka A., Filipiak K.J.
Cell-derived microvesicles in cardiovascular diseases and antiplatelet therapy monitoring - A lesson for future trials? Current evidence, recent progresses and perspectives of clinical application (pdf, 824 kB)
 Int. J. Cardiol. 2017; 226: 93-102